Emergent BioSolutions Gets FDA Greenlight for Multipacks of Narcan is drawing significant interest across the industry.
By Elias Schisgall Emergent BioSolutions received Food and Drug Administration approval for its multipack configuration of Narcan, the opioid-overdose-reversal drug. The company said Friday...
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →